Novotech

Novotech Novotech is a multi-award winning contract research organization (CRO).

Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase. Founded in 1996, we’re headquartered in Australia, and have offices in Sydney, Brisbane and Melbourne, and across the Asia-Pacific region, including China, Hong Kong, India, Mal

aysia, New Zealand, Philippines, Singapore, South Korea, Taiwan and Thailand. We’re internationally recognized in the industry as a leading regional full-service CRO, with services including clinical trials, biostatistics, data management, regulatory affairs, audits and medical writing.

Today is World RNA Day, a chance to recognize the impact RNA science is having across medicine.Over the past few years, ...
01/08/2026

Today is World RNA Day, a chance to recognize the impact RNA science is having across medicine.

Over the past few years, RNA-based therapies have moved from scientific promise to real clinical progress. Whether it's mRNA vaccines, RNA interference, or emerging RNA technologies, researchers continue to push the science forward across infectious diseases, oncology, rare diseases, and many other therapeutic areas.

Behind every new therapy is a great deal of clinical research. Bringing these treatments to patients takes experienced investigators, research sites, study participants, and close collaboration across the clinical research community.

At Novotech, we're proud to work alongside biotech and pharmaceutical companies developing RNA therapies through clinical programs across Asia-Pacific, North America, and Europe.

On World RNA Day, we thank everyone contributing to this progress and to the future of RNA research.

28/07/2026

Today, on World Hepatitis Day, we join the global community in raising awareness of viral hepatitis and the importance of advancing prevention, diagnosis, and treatment.

Despite significant progress, millions of people worldwide continue to live with hepatitis B and hepatitis C. Continued scientific innovation and clinical research remain essential to improving outcomes and working toward the global elimination of viral hepatitis.

For more than two decades, Novotech has partnered with biotech and pharmaceutical sponsors developing innovative viral hepatitis therapies. Having supported 130+ hepatitis A, B, C, and D clinical trials, we bring deep therapeutic expertise and global clinical development capabilities to help advance new treatment options for patients worldwide.

To mark World Hepatitis Day, we're proud to share The Next Frontier series presented by BIO and produced for them by BBC StoryWorks Commercial Productions to see how Novotech partners with sponsors to accelerate Hepatitis B clinical trials.

We’re pleased to announce that  Dylan Matzinger has joined Novotech as Chief Business Officer, strengthening our Executi...
23/06/2026

We’re pleased to announce that Dylan Matzinger has joined Novotech as Chief Business Officer, strengthening our Executive Leadership Team.

Dylan brings nearly 20 years of experience across clinical research, biopharma, and global commercial operations, with a strong track record of building high-performing teams and driving commercial growth.

Dylan’s industry expertise and leadership will support Novotech’s continued global expansion and commitment to advancing innovative therapies.

We’re excited to welcome Dylan to the team.

Today is International Clinical Trials Day.It’s a moment to recognize the people behind every clinical trial, working ac...
20/05/2026

Today is International Clinical Trials Day.

It’s a moment to recognize the people behind every clinical trial, working across teams and regions to keep progress moving forward.

Clinical trials are complex, but they succeed because of the people involved at every step.

At Novotech, we are proud to partner with teams around the world who are helping shape the future of healthcare through clinical research.

11/05/2026

We’re pleased to welcome Elaina N. Haeuber, MS as Senior Vice President, Global Project Management at Novotech.

With more than 20 years of global experience in clinical development and operations, Elaina has led complex, multinational programs and built high-performing teams.

Her appointment strengthens our global project management capability as we continue to support increasingly complex development programs.

Join us in welcoming Elaina to the Novotech team.

07/05/2026

We’re excited to welcome Susan Johnson as Managing Director, North America at Novotech.

Susan brings 20+ years of experience in clinical operations across biotech, pharma, and CROs, with a strong track record leading complex programs and partnering closely with sponsors.

Her appointment further strengthens our North America leadership as we continue to support increasingly complex development programs.

Please join us in welcoming Susan to the team.

Strong clinical programs start with the right foundations: access to the right sites and realistic feasibility from day ...
06/05/2026

Strong clinical programs start with the right foundations: access to the right sites and realistic feasibility from day one.

At Novotech, we’re taking a more integrated approach—bringing site engagement, partnerships, and feasibility together to drive better outcomes for both delivery and growth.

We’re currently looking for a Senior Director, Site Engagement & Feasibility to lead this effort within our Clinical Operations team.

This is a global role, working across Clinical, Therapeutic Strategy, Commercial, and Executive Leadership—connecting site strategy with study planning and ex*****on.

If you’ve worked in this space, you know how impactful this can be.

Apply Now: https://fa-euzi-saasfaprod1.fa.ocs.oraclecloud.com/hcmUI/CandidateExperience/en/sites/CX_1/job/3871

01/05/2026

We’re pleased to welcome Kristin Brown as our new Chief Legal Officer.

Kristin brings over 20 years of global leadership experience, having led Legal, Risk, Internal Audit and ESG functions, driven major transformation initiatives, strengthened governance frameworks, and enhanced operational efficiency through technology.

She has extensive experience advising executive teams on legal, regulatory and risk strategy across APAC, EMEA, the Middle East and the US.

In her new role, Kristin will partner with our executive team to strengthen capabilities and support our continued global growth.

Welcome, Kristin.

Address

Level 52, 9 Raffles Place, Republic Plaza
Central Region
048619

Alerts

Be the first to know and let us send you an email when Novotech posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Novotech:

Shortcuts

Share